The upregulation of YY1, E2F4 and NRF1 in the liver of HCC patients was also confirmed through the analysis of cohorts of patients downloaded from GEO (i.e., GSE62232 and GSE6764; Supplementary Figure S6). Here, NRF1 is linked to hepatocellular carcinoma.